Hong Kong Island, Hong Kong, China The common things for fund are deals in the range of more than 100 millions dollars. The typical startup value when the investment from ABC International is more than 1 billion dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the ABC International, startups are often financed by Qiming Venture Partners, Xiaopeng He, Tongren Boda. The meaningful sponsors for the fund in investment in the same round are SenseTime, YF Capital (Yunfeng Capital), Xiaopeng He.
Among the most successful fund investment fields, there are Software, Retail. Among the most popular portfolio startups of the fund, we may highlight Suning Sports, WeRide.ai, CGeneTech. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.
Related Funds
| Fund Name | Location |
| aCommerce | Bangkok, Krung Thep, Thailand |
| Anchors Capital | China, Guangdong, Shenzhen |
| CoCapital | - |
| Crush Ventures | California, Los Angeles, United States |
| CTS Capital | - |
| District Ventures Capital | Alberta, Calgary, Canada |
| DNA Capital | Brazil, São Paulo, Sao Paulo |
| Gruppo Bancario Credito Valtellinese | Italy, Palermo, Sicilia |
| Hang Lung Group | - |
| Holt Family Investments | Georgia, Rome, United States |
| Idea Ventures | Burbank, California, United States |
| Neuron.VC | California, Redwood City, United States |
| Persistence Partners | California, Carpinteria, United States |
| S3 Ventures | Austin, Texas, United States |
| SHLOMO ELIA INVESTMENTS LTD | - |
| Tagehus | Stockholm, Stockholm County, Sweden |
| Unicore Technology Company | - |
| Xinhuadou | China, Shanghai |
| Yike Zhengrun Investment Group | - |
| Zhitou Touzi | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Raypaitech | 21 Nov 2023 | Hongkou District, China | |||
Excell Biology | $15M | 10 May 2023 | Shanghai, Shanghai, China | ||
CanSemi | 29 Nov 2022 | Guangzhou, Guangdong, China | |||
Voyah | $773M | 18 Nov 2022 | China, China | ||
Hithium | $309M | 19 Oct 2022 | Xiamen, China | ||
Coherent Biopharma | 31 Jul 2022 | Suzhou, Jiangsu, China | |||
Kangpu Bio-Pharma | $38M | 10 May 2021 | Shanghai, China | ||
Fukey Technology | $15M | 24 Mar 2021 | Shanghai, Shanghai, China | ||
| $150M | 23 Feb 2021 | Shanghai, China |
– WuXi Diagnostics secured a US$150m Series B financing round to accelerate market penetration in the global diagnostics sector.
– The round was joined by new investors including Thermo Fisher, Shiyu Capital, ABC International, Sunland Capital, and CCBI Tech Venture.
– WuXi Diagnostics will deploy funds to strengthen its open-access innovation enabling platform, advance its integrated diagnostics R&D pipeline, and accelerate market penetration in the global diagnostics sector.
– WuXi Diagnostics is the first platform company in China focusing on integrated diagnostics. Since its establishment in 2018, WuXi Diagnostics has continuously promoted the clinical practice of integrated diagnostics by virtue of its open-access innovation enabling platform, centered on multi-omics clinical data from multidisciplinary technologies.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Raypaitech | 21 Nov 2023 | Hongkou District, China | |||
Excell Biology | $15M | 10 May 2023 | Shanghai, Shanghai, China | ||
CanSemi | 29 Nov 2022 | Guangzhou, Guangdong, China | |||
Voyah | $773M | 18 Nov 2022 | China, China | ||
Hithium | $309M | 19 Oct 2022 | Xiamen, China | ||
Coherent Biopharma | 31 Jul 2022 | Suzhou, Jiangsu, China | |||
Kangpu Bio-Pharma | $38M | 10 May 2021 | Shanghai, China | ||
Fukey Technology | $15M | 24 Mar 2021 | Shanghai, Shanghai, China | ||
| $150M | 23 Feb 2021 | Shanghai, China |
